These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 27816294

  • 21. Guidelines for the management of tinea capitis in children.
    Kakourou T, Uksal U, European Society for Pediatric Dermatology.
    Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140
    [Abstract] [Full Text] [Related]

  • 22. Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long.
    Bar J, Samuelov L, Sprecher E, Mashiah J.
    Mycoses; 2019 Oct; 62(10):949-953. PubMed ID: 31343780
    [Abstract] [Full Text] [Related]

  • 23. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
    Möhrenschlager M, Korting HC, Seidl HP, Ring J, Abeck D.
    Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
    [Abstract] [Full Text] [Related]

  • 24. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST, Cucé LC, Foss NT, Marques SA, Santamaria JR.
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [Abstract] [Full Text] [Related]

  • 25. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC, Smith CH, Cerio R, Marsden RA, Midgley G, Beard AL, Higgins EM, Hay RJ.
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [Abstract] [Full Text] [Related]

  • 26. Microsporum canis infections in children: results of a new oral antifungal therapy.
    Ginter G.
    Mycoses; 1996 Feb; 39(7-8):265-9. PubMed ID: 9009643
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic options in the treatment of tinea capitis.
    Chan YC, Friedlander SF.
    Expert Opin Pharmacother; 2004 Feb; 5(2):219-27. PubMed ID: 14996619
    [Abstract] [Full Text] [Related]

  • 28. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M, Monod M, Baudraz-Rosselet F, Panizzon RG.
    Dermatology; 1998 Feb; 197(4):361-7. PubMed ID: 9873175
    [Abstract] [Full Text] [Related]

  • 29. Tinea capitis: a treatment update.
    Roberts BJ, Friedlander SF.
    Pediatr Ann; 2005 Mar; 34(3):191-200. PubMed ID: 15792111
    [Abstract] [Full Text] [Related]

  • 30. Tinea capitis: advances and a needed paradigm shift.
    Le TK, Cohen BA.
    Curr Opin Pediatr; 2021 Aug 01; 33(4):387-391. PubMed ID: 34226424
    [Abstract] [Full Text] [Related]

  • 31. The efficacy and safety of terbinafine in children.
    Gupta AK, Cooper EA, Lynde CW.
    Dermatol Clin; 2003 Jul 01; 21(3):511-20. PubMed ID: 12956204
    [Abstract] [Full Text] [Related]

  • 32. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
    Foster KW, Friedlander SF, Panzer H, Ghannoum MA, Elewski BE.
    J Am Acad Dermatol; 2005 Nov 01; 53(5):798-809. PubMed ID: 16243128
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans.
    Desgarennes MD, Godoy MR, Palencia AB.
    J Am Acad Dermatol; 1996 Jul 01; 35(1):114-6. PubMed ID: 8682948
    [No Abstract] [Full Text] [Related]

  • 34. In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients.
    Gupta AK, Williams JV, Zaman M, Singh J.
    Med Mycol; 2009 Dec 01; 47(8):796-801. PubMed ID: 19212895
    [Abstract] [Full Text] [Related]

  • 35. A network meta-analysis on the efficacy and safety of monotherapies for tinea capitis, and an assessment of evidence quality.
    Gupta AK, Bamimore MA, Renaud HJ, Shear NH, Piguet V.
    Pediatr Dermatol; 2020 Nov 01; 37(6):1014-1022. PubMed ID: 32897584
    [Abstract] [Full Text] [Related]

  • 36. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study.
    Gupta AK, Dlova N, Taborda P, Morar N, Taborda V, Lynde CW, Konnikov N, Borges M, Raboobee N, Summerbell RC, Adam P, Hofstader SL, Aboobaker J.
    Br J Dermatol; 2000 May 01; 142(5):965-8. PubMed ID: 10809856
    [Abstract] [Full Text] [Related]

  • 37. Microsporum canis tinea capitis in an 8-month-old infant successfully treated with 2 weekly pulses of oral itraconazole.
    Koumantaki E, Georgala S, Rallis E, Papadavid E.
    Pediatr Dermatol; 2001 May 01; 18(1):60-2. PubMed ID: 11207976
    [Abstract] [Full Text] [Related]

  • 38. Tinea capitis: fluconazole in Trichophyton tonsurans infection.
    Mercurio MG, Silverman RA, Elewski BE.
    Pediatr Dermatol; 1998 May 01; 15(3):229-32. PubMed ID: 9655323
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
    Dastghaib L, Azizzadeh M, Jafari P.
    J Dermatolog Treat; 2005 Feb 01; 16(1):43-6. PubMed ID: 15897167
    [Abstract] [Full Text] [Related]

  • 40. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M, Schnopp C, Fesq H, Strom K, Beham A, Mempel M, Thomsen S, Brockow K, Wessner DB, Heidelberger A, Ruhdorfer S, Weigl L, Seidl HP, Ring J, Abeck D.
    Br J Dermatol; 2000 Nov 01; 143(5):1011-5. PubMed ID: 11069511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.